Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
about
Blood pressure targets for the treatment of patients with hypertension and cardiovascular diseaseBlood pressure targets for hypertension in people with diabetes mellitusThe J-Curve Phenomenon in HypertensionUnderstanding and treating hypertension in diabetic populationsElderly hypertensives: how are they different?Hypertension and chronic kidney disease: controversies in pathogenesis and treatmentWhat is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsDifferences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysisPre-hypertension: how low to go and do drugs have a role?Diabetic kidney disease: a report from an ADA Consensus ConferenceAngiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsOscillating blood pressure therapeutic target in type 2 diabetes patients with hypertensionCurrent and Future Treatment of Hypertension in the SPRINT EraThe 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapyEffects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisPhysician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional studyBlood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney diseaseFunctional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data.INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.White-coat hypertension should not be treated in subjects with diabetes.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathySex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort StudyBlood Pressure Management for Stroke Prevention and in Acute StrokeWhen tight blood pressure control is not for everyone: a new model for performance measurement in hypertension.BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 IndividualsBlood pressure targets in the very old: development of a tool in a geriatric day hospital.Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBIsolated systolic hypertension and incident heart failure in older adults: a propensity-matched study.Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertensionA combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health StudyAntihypertensive medications and serious fall injuries in a nationally representative sample of older adults.2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapyOutcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.End organ damage in hypertension.
P2860
Q24201957-6BA7A061-EEBB-4808-ABF7-41109D3B11D8Q24202854-F7F7C129-E656-4DD2-98EB-813E1A4A0710Q26738834-1FABD77B-0B1B-4D1F-AA0D-4C8F5098B285Q26778662-2964D76C-26E2-4A0A-AA28-4B52D6699076Q26830725-42D6AB1D-F950-4DD9-99E6-04B0846CE5A2Q26851271-825604FC-BA24-46D4-A451-60A0A114FE76Q26864349-8DFD5805-D4EE-485A-AA9C-52C49D81C31FQ27001759-2329BE30-174F-4BA2-8451-9EF6862FA99FQ27007552-85DC7137-2DD1-42EE-863F-5B75AF4C5806Q27012546-95D219C4-21D9-4358-9271-2FE6D73A6576Q27023161-001E2F1A-7AAB-4975-AAD6-109A334FAFB6Q28068633-8D596182-3106-4850-B79A-62D847A01011Q28073270-15A09D53-E4F4-43C7-A02E-BA16BE249917Q28211654-E7DFC251-8ADC-46F9-B30F-4A861DEB74CEQ28482437-21C68556-6142-44B9-A708-5F67E6FDF150Q28740395-DB4BCF72-6737-4890-A81B-27509BA4A822Q30410815-BD9308CD-9529-4201-9DF9-14F8F5E3B6D6Q30429482-C225E27E-A18A-4390-A66D-082F32AC31A7Q31018707-4D56740E-9BA3-44FB-9E8C-F736C445B034Q33567530-078CE0B1-4CA9-41C3-BC80-9417DCD75471Q33610794-0ED61921-EF24-4754-A471-F401B1391A65Q33647497-85DFB58E-62B6-46F3-BE44-C8C3B84F08AFQ33759059-B0B87D45-DC14-4D19-A71A-523EF5349CA3Q33783596-C63551DE-8731-4217-BFA5-429C784676D1Q33805544-3B133B55-FC2A-4212-B045-3004D943584DQ33814858-A78D4BED-0F47-4730-A7C1-49B8D0C84CDDQ33834035-5891662D-9130-494A-8C95-BEE1B6C03983Q33894758-63A4147F-FCEC-4131-8482-5BA176D5517EQ33908782-3C59F843-EA89-4380-B249-80506094ADCEQ33921465-22DFDC0E-B3DD-465D-85BE-9339C9D95DFCQ33987980-56688FFA-F9D5-4A88-8391-5C498EF1AE06Q34018990-DC1E925F-D138-40EB-BCA0-10CFD0F19617Q34051465-36D06AE5-27E1-4D8B-931B-F2B4A28B89C2Q34061043-90935F82-0913-4AE6-896F-473AF6E15A9FQ34321437-F2C5E72B-A2A3-4EB5-AC33-A4791D5C2274Q34367324-235528D1-36F2-4A01-A382-E53448DA0479Q34396234-2BDD736F-7E63-4117-B36C-DCAF966D416DQ34432806-02035BA7-A9FF-4A5C-A059-FF560FBF93A8Q34432935-649764D7-952F-4F66-8AAB-0656A7C4F06BQ34444944-8D74206A-9785-44B8-9F74-1E036071DD91
P2860
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@en
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@nl
type
label
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@en
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@nl
prefLabel
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@en
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@nl
P2093
P1476
Dogma disputed: can aggressive ...... y artery disease be dangerous?
@en
P2093
Ann C Hewkin
Annette Champion
Athanase Benetos
C Richard Conti
Carl J Pepine
Franz H Messerli
Rainer Kolloch
Stuart Kupfer
P304
P356
10.7326/0003-4819-144-12-200606200-00005
P407
P577
2006-06-01T00:00:00Z